CITYSCAPE: 1L tiragolumab + atezolizumab vs placebo + atezolizumab in PD-L1-selected NSCLC VJOncology 1:12 2 years ago 209 Далее Скачать
CITYSCAPE: Tiragolumab plus atezolizumab for non-small cell lung cancer ecancer 3:13 4 years ago 780 Далее Скачать
ASCO Lung Cancer Roundtable - NSCLC - The CITYSCAPE Trial: Anti TIGIT & Immune Checkpoint Inhibitor GRACE - Global Resource for Advancing Cancer Education 8:35 4 years ago 647 Далее Скачать
Dr Melissa Johnson: Tiragolumab/Atezolizumab Potential New Treatment Option for NSCLC AJMCtv 4:05 4 years ago 514 Далее Скачать
Dr Melissa Johnson: Tiragolumab Plus Atezolizumab Improves Objective Response in CITYSCAPE Trial AJMCtv 2:03 4 years ago 489 Далее Скачать
Tiragolumab and atezolizumab in metastatic esophageal cancer VJOncology 0:39 3 years ago 588 Далее Скачать
TIGIT: harnessing the power of the immune system to help fight cancer Roche 3:45 2 years ago 36 355 Далее Скачать
Dr Chitresh Aggarwal | Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a 1L CRSF - Cancer Research and Statistic Foundation 6:04 1 year ago 40 Далее Скачать
What role does TIGIT inhibition have in treating hepatocellular carcinoma? VJOncology 3:52 1 year ago 201 Далее Скачать
Edward Garon, MD, examines dual immunotherapy approach in the CITYSCAPE trial OBRoncology 2:50 4 years ago 78 Далее Скачать
Unexpected safety data in TREASURE: thoracic radiotherapy with atezolizumab in SCLC VJOncology 2:36 1 year ago 53 Далее Скачать
